nabCapital CEO presents Science in Business Award

30 November

nabCapital CEO John Hooper, this week, presented the 2008 Science in Business Awards for research commercialisation projects which included an emerging vaccine technology developed by veski innovation fellow Dr Gareth Forde.

At a presentation event on Wednesday, 26 November 2008, hosted by Dr Alan Finkel, Chancellor of Monash University, Chief Executive Officer - nabCapital Mr John Hooper presented the nabCapital Science in Business Awards to the winning students from the Monash University Master of Business (Commercialising Science & Technology) 2008 class.

veski innovation fellow Dr Gareth Fordes' emerging vaccine technology: Efficient production of plasmid DNA vaccines -An invention, currently being reviewed by a number of international companies, provides a means of rapidly and efficiently producing large quantities of plasmid DNA vaccines, with potential for vaccination against pandemics and diseases such as malaria. It is already being used in the development of an experimental malaria vaccine at Monash.

What's On

September

S M T W T F S
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 

What people say about veski

“Our research program is focused on working with industrial partners to develop novel therapeutics that will transform the treatment of chronic inflammatory diseases such as IBD.”

- Professor Colby Zaph

Tweets from @veskiorg